The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22

Massimo Pancione, Andrea Remo, Caterina Zanella, Lina Sabatino, Arturo D. Blasi, Carmelo Laudanna, Laura Astati, Michele Rocco, Delfina Bifano, Paolo Piacentini, Laura Pavan, Alberto Purgato, Filippo Greco, Alberto Talamini, Andrea Bonetti, Michele Ceccarelli, Roberto Vendraminelli, Erminia Manfrin, Vittorio Colantuoni

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

INI1 (Integrase interactor 1), also known as SMARCB1, is the most studied subunit of chromatin remodelling complexes. Its role in colorectal tumorigenesis is not known.We examined SMARCB1/INI1 protein expression in 134 cases of colorectal cancer (CRC) and 60 matched normal mucosa by using tissue microarrays and western blot and categorized the results according to mismatch repair status (MMR), CpG island methylator phenotype, biomarkers of tumor differentiation CDX2, CK20, vimentin and p53. We validated results in two independent data sets and in cultured CRC cell lines.Herein, we show that negative SMARCB1/INI1 expression (11% of CRCs) associates with loss of CDX2, poor differentiation, liver metastasis and shorter patients' survival regardless of the MMR status or tumor stage. Unexpectedly, even CRCs displaying diffuse nuclear INI1 staining (33%) show an adverse prognosis and vimentin over-expression, in comparison with the low expressing group (56%). The negative association of SMARCB1/INI1-lack of expression with a metastatic behavior is enhanced by the TP53 status. By interrogating global gene expression from two independent cohorts of 226 and 146 patients, we confirm the prognostic results and identify a gene signature characterized by SMARCB1/INI1 deregulation. Notably, the top genes of the signature (BCR, COMT, MIF) map on the long arm of chromosome 22 and are closely associated with SMARCB1/INI1.Our findings suggest that SMARCB1/INI1-dysregulation and genetic hot-spots on the long arm of chromosome 22 might play an important role in the CRC metastatic behavior and be clinically relevant as novel biomarkers.

Original languageEnglish
Article number297
JournalJournal of translational medicine
Volume11
Issue number1
DOIs
Publication statusPublished - 17 Sep 2013
Externally publishedYes

Keywords

  • Chromosome 22
  • Colorectal cancer
  • Integrase interactor 1

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22'. Together they form a unique fingerprint.

  • Cite this

    Pancione, M., Remo, A., Zanella, C., Sabatino, L., Blasi, A. D., Laudanna, C., Astati, L., Rocco, M., Bifano, D., Piacentini, P., Pavan, L., Purgato, A., Greco, F., Talamini, A., Bonetti, A., Ceccarelli, M., Vendraminelli, R., Manfrin, E., & Colantuoni, V. (2013). The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22. Journal of translational medicine, 11(1), [297]. https://doi.org/10.1186/1479-5876-11-297